Frequently Asked Questions

Amilieu is a clinical AI governance platform that helps healthcare organisations oversee the AI systems they deploy. It provides structured oversight, audit trails, and regulator-ready evidence without participating in clinical decision-making.

No. Amilieu does not diagnose patients, make predictions, or provide treatment recommendations. It sits around AI systems to support governance, accountability, and compliance rather than clinical care.

Amilieu is designed for hospital governance teams, clinical safety leaders, digital health units, compliance and risk teams, and organisations responsible for overseeing clinical AI deployments.

No. Amilieu is designed to minimise clinical risk. In its current version, patient identifiers and free-text clinical content are explicitly blocked. Governance-relevant data flows one-way into Amilieu without live clinical integration.

Yes. Amilieu is model-agnostic and vendor-neutral. It operates on standardised metadata and governance signals rather than vendor-specific implementations, allowing organisations to oversee multiple AI systems consistently.

Yes. Amilieu is designed for incremental adoption. Organisations can start with a simple AI registry and manual governance workflows, and progressively enable more advanced monitoring and reporting as maturity increases.

Amilieu is deployed in secure cloud infrastructure within Australia, with logical tenant isolation, encryption, and enterprise-grade security controls.